Literature DB >> 16271316

Prospective, randomized trial of trimethoprim/sulfamethoxazole vs. pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis: discussion.

Gary N Holland1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16271316     DOI： 10.1016/j.ophtha.2005.09.026

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  6 in total

Review 1.  Uveitis: advances in understanding of pathogenesis and treatment.

Authors:  Russell W Read
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

Review 2.  Ocular toxoplasmosis II: clinical features, pathology and management.

Authors:  Nicholas J Butler; João M Furtado; Kevin L Winthrop; Justine R Smith
Journal:  Clin Exp Ophthalmol       Date:  2012-09-17       Impact factor: 4.207

3.  [Diagnosis and treatment of ocular toxoplasmosis : a survey of German-speaking ophthalmologists].

Authors:  N Torun; Z Sherif; J Garweg; U Pleyer
Journal:  Ophthalmologe       Date:  2008-11       Impact factor: 1.059

4.  Azithromycin versus Sulfadiazine and Pyrimethamine for non-vision-threatening toxoplasmic retinochoroiditis: a pilot study.

Authors:  Konstantinos Balaskas; Jean Vaudaux; Noémie Boillat-Blanco; Yan Guex-Crosier
Journal:  Med Sci Monit       Date:  2012-05

5.  Experimental Models of Ocular Infection with Toxoplasma Gondii.

Authors:  Agata Dukaczewska; Roberto Tedesco; Oliver Liesenfeld
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-12-04

Review 6.  Clinical features and treatment of ocular toxoplasmosis.

Authors:  Young-Hoon Park; Ho-Woo Nam
Journal:  Korean J Parasitol       Date:  2013-08-30       Impact factor: 1.341
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.